4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000950170-24-110141
Chief Financial Officer sold 17,146 shares at $9.00 ($154,314)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moran Kyle Chief Financial Officer | 2024-09-25 | Sale 10b5-1 | −17,146 | $9.00 | $154,314 | 19,777 | D |
| Open-market sales · 17,146 sh · avg $9.00 · $154,314 | |||||||
Loading xslF345X05/ownership.xml…